SZSE:300158 (China)
Â
Class A
Â¥
3.92
(-0.25%)
Jun 20
Current and historical daily PE Ratio for Shanxi Zhendong Pharmaceutical Co Ltd (
) from 2011 to Jun 19 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Shanxi Zhendong Pharmaceutical stock (SZSE:300158) PE ratio as of Jun 19 2024 is 0.
More Details
Shanxi Zhendong Pharmaceutical Co Ltd (SZSE:300158) PE Ratio (TTM) Chart
Shanxi Zhendong Pharmaceutical Co Ltd (SZSE:300158) PE Ratio (TTM) Historical Data
View and export this data going back to 2011. Start your Free Trial
Total 1208
- 1
- 2
- 3
- 4
- 5
- 6
- 14
Shanxi Zhendong Pharmaceutical PE Ratio (TTM) Historical Data | |||
---|---|---|---|
Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
2024-06-20 | At Loss | 2024-04-12 | At Loss |
2024-06-19 | At Loss | 2024-04-11 | At Loss |
2024-06-18 | At Loss | 2024-04-10 | At Loss |
2024-06-17 | At Loss | 2024-04-09 | At Loss |
2024-06-14 | At Loss | 2024-04-08 | At Loss |
2024-06-13 | At Loss | 2024-04-03 | At Loss |
2024-06-12 | At Loss | 2024-04-02 | At Loss |
2024-06-11 | At Loss | 2024-04-01 | At Loss |
2024-06-07 | At Loss | 2024-03-29 | At Loss |
2024-06-06 | At Loss | 2024-03-28 | At Loss |
2024-06-05 | At Loss | 2024-03-27 | At Loss |
2024-06-04 | At Loss | 2024-03-26 | At Loss |
2024-06-03 | At Loss | 2024-03-25 | At Loss |
2024-05-31 | At Loss | 2024-03-22 | At Loss |
2024-05-30 | At Loss | 2024-03-21 | At Loss |
2024-05-29 | At Loss | 2024-03-20 | At Loss |
2024-05-28 | At Loss | 2024-03-19 | At Loss |
2024-05-27 | At Loss | 2024-03-18 | At Loss |
2024-05-24 | At Loss | 2024-03-15 | At Loss |
2024-05-23 | At Loss | 2024-03-14 | At Loss |
2024-05-22 | At Loss | 2024-03-13 | At Loss |
2024-05-21 | At Loss | 2024-03-12 | At Loss |
2024-05-20 | At Loss | 2024-03-11 | At Loss |
2024-05-17 | At Loss | 2024-03-08 | At Loss |
2024-05-16 | At Loss | 2024-03-07 | At Loss |
2024-05-15 | At Loss | 2024-03-06 | At Loss |
2024-05-14 | At Loss | 2024-03-05 | At Loss |
2024-05-13 | At Loss | 2024-03-04 | At Loss |
2024-05-10 | At Loss | 2024-03-01 | At Loss |
2024-05-09 | At Loss | 2024-02-29 | At Loss |
2024-05-08 | At Loss | 2024-02-28 | At Loss |
2024-05-07 | At Loss | 2024-02-27 | At Loss |
2024-05-06 | At Loss | 2024-02-26 | At Loss |
2024-04-30 | At Loss | 2024-02-23 | At Loss |
2024-04-29 | At Loss | 2024-02-22 | At Loss |
2024-04-26 | At Loss | 2024-02-21 | At Loss |
2024-04-25 | At Loss | 2024-02-20 | At Loss |
2024-04-24 | At Loss | 2024-02-19 | At Loss |
2024-04-23 | At Loss | 2024-02-08 | At Loss |
2024-04-22 | At Loss | 2024-02-07 | At Loss |
2024-04-19 | At Loss | 2024-02-06 | At Loss |
2024-04-18 | At Loss | 2024-02-05 | At Loss |
2024-04-17 | At Loss | 2024-02-02 | At Loss |
2024-04-16 | At Loss | 2024-02-01 | At Loss |
2024-04-15 | At Loss | 2024-01-31 | At Loss |
Shanxi Zhendong Pharmaceutical Co Ltd (SZSE:300158) PE Ratio (TTM) Comparison
Company | Market Cap(Mil) | PE Ratio (TTM) |
---|
Business Description
Business Description
Shanxi Zhendong Pharmaceutical Co Ltd
NAICS : 325412
SIC : 2834
ISIN : CNE100000YR9
Share Class Description:
SZSE:300158: Class ACompare
Compare
Traded in other countries / regions
300158.China IPO Date
2011-01-07Description
Shanxi Zhendong Pharmaceutical Co Ltd together with its subsidiaries, researches, develops, manufactures, and markets pharmaceutical products and Chinese medicines in China. It offers anticancer drugs, cardiovascular disease prevention and control drugs and anti-infection drugs among others. The company categorizes its product as Chinese & Western Medicine, Wuhe Food, Home Care Products and Traditional Chinese Medicine.